Effect of hyperoxia on exercise performance in COPD: Randomized trial Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016
Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013
Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Efficacy and safety of abediterol (LAS100977) in stable asthma: Phase II, randomized, crossover study Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
A prospective observational study of the impact of COPD on daily life following the initiation of indacaterol Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study Source: Eur Respir J 2010; 35: 532-539 Year: 2010
Combined tiotropium + olodaterol influences physical functioning in COPD: Results of an open-label observational study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial*): No impact on hospital admissions and quality of life (QOL) Source: International Congress 2014 – Best abstracts in chronic care Year: 2014
Effects of ghrelin on the dyspnea pattern in cachectic COPD: Exploratory analysis of a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
The effect of COPD and FEV1 decline on health-related quality of life: A longitudinal, population-based study Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
An auto-titrating intelligent oxygen therapy (iO2T) system in COPD patients: A randomised cross-over trial Source: International Congress 2015 – Tele-rehabilitation in chronic lung diseases Year: 2015
A randomised double-blind placebo-controlled trial of the effect of inhaled heparin on lung function, hyperinflation and exercise capacity in patients with COPD Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016
Efficacy of the Plasma Cluster® device in mild to moderate asthmatic children: A randomized, double-blind, placebo-controlled, proof-of-concept trial Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
LATE-BREAKING ABSTRACT: The benefits of [italic]Nigella sativa[/italic] oil supplementation on asthma inflammation: A randomised, double-blind, placebo-controlled, phase II trial Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016
A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD : AIRFLOW-2 One Year Outcomes Source: International Congress 2019 – Interventional pulmonology: a mixture of spices Year: 2019
Quality control of spirometry: a lesson from the BRONCUS trial Source: Eur Respir J 2005; 26: 1104-1109 Year: 2005
Roflumilast for stable COPD: Meta-analysis of randomized controlled trials Source: International Congress 2014 – Clinical presentations Year: 2014
A phase III, multi-site, randomised, double blind, placebo controlled parallel arm study of daily extended release (ER) morphine for chronic breathlessness Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016
Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial Source: Eur Respir J 2013; 41: 556-564 Year: 2013